PRKDC and colorectal carcinoma: We found that the basal levels of DNA-PKcs phosphorylation at Ser2056 (a marker for DSB-induced DNA-PKcs activation [15]) were increased in the four different OR CRC cell lines compared with their oxaliplatin-sensitive counterparts (Fig. 1c).